NEW YORK (360Dx) – T2 Biosystems reported after the close of the market on Thursday that its third quarter revenues were essentially flat year over year, despite a 27 percent jump in product revenues.

For the three months ended Sept. 30, the firm recorded total revenues of $1.1 million, the same as a year ago, and even with the consensus Wall Street estimate. Product revenues climbed to $739,000 from $580,000 in Q3 2016, but research revenues slid 27 percent to $369,000 from $504,000.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.